Business development teams are navigating unchartered waters when it comes to assessing the current market for dealmaking. Amid the onset of the Covid-19 pandemic, the majority of sale processes came to a screeching halt. But as the economy slowly reopens and sellers begin to dip their feet back into the market, key questions remain. What can strategic acquirers do to properly assess deals under renewed volatility? Bankers have kicked around the term Ebitdac, or earnings before interest, taxes, depreciation, amortization and coronavirus, to describe alterations being made to the popular Ebitda valuation metrics, but is that a fair way for both buyers and sellers to assess valuations now that world has changed? What do valuations look like today, and how can we expect them to progress over the coming months? Finally, having entered the pandemic during an already competitive market, how can sellers best prepare for this new arena, where buyers are likely to go over deals with a fine-toothed comb to identify the most stable and recession-proof businesses?
In partnership with Cooley, The Deal seeks to answer these questions, and more, as we sit down with leading corporate dealmakers and advisers.
Ms. Jarrett currently serves as Vice President, Corporate Development and Capital Markets for Uber Technologies Inc.
Fill out the form to reach our team regarding your inquiries related to Registration, Sales/Sponsorship, Speaking, and Press. You can also subscribe to the Events Newsletter to keep up-to-date with The Deal Events.
A series of discussions for healthcare dealmakers on the current opportunities, pitfalls and latest developments in the M&A market.
Experts discuss trends in the tech M&A market including virtual dealmaking, the proliferation of SPACs, stock sell-off and cross border deals.